Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gaspar

Showing results (171-180 of 192) with videos related to

Pageof 20
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 25, 2017
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)Paul W Sperduto, Wen Jiang, Paul D Brown, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2017
The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain MetastasesPaul W Sperduto, Wen Jiang, Paul D Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2020
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline UpdateNasser H Hanna, Bryan J Schneider, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2021
Treatment for Brain Metastases: ASCO-SNO-ASTRO GuidelineMichael A Vogelbaum, Paul D Brown, Hans Messersmith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2019
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized StudyDaniel R Gomez, Chad Tang, Jianjun Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastasesPaul W Sperduto, Norbert Kased, David Roberge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2019
Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 TrialAndrea Bezjak, Rebecca Paulus, Laurie E Gaspar, et al.
International Journal of Radiation Oncology, Biology, Physics|April 19, 2011
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastasesPaul W Sperduto, Norbert Kased, David Roberge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2021
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline UpdateNasser H Hanna, Andrew G Robinson, Sarah Temin, et al.
The Lancet. Oncology|September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO groupNancy U Lin, Jeffrey S Wefel, Eudocia Q Lee, et al.
Pageof 20

Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
International Journal of Radiation Oncology, Biology, Physics|October 25, 2017
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)Paul W Sperduto, Wen Jiang, Paul D Brown, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2017
The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain MetastasesPaul W Sperduto, Wen Jiang, Paul D Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2020
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline UpdateNasser H Hanna, Bryan J Schneider, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2021
Treatment for Brain Metastases: ASCO-SNO-ASTRO GuidelineMichael A Vogelbaum, Paul D Brown, Hans Messersmith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2019
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized StudyDaniel R Gomez, Chad Tang, Jianjun Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastasesPaul W Sperduto, Norbert Kased, David Roberge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2019
Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 TrialAndrea Bezjak, Rebecca Paulus, Laurie E Gaspar, et al.
International Journal of Radiation Oncology, Biology, Physics|April 19, 2011
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastasesPaul W Sperduto, Norbert Kased, David Roberge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2021
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline UpdateNasser H Hanna, Andrew G Robinson, Sarah Temin, et al.
The Lancet. Oncology|September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO groupNancy U Lin, Jeffrey S Wefel, Eudocia Q Lee, et al.
Pageof 20